Keywords: آنتی ژن اختصاصی پروستات; PSA; prostate specific antigen; CT; computed tomography; IV; intravenous; MRI; magnetic resonance imaging; Radical retropubic prostatectomy; Pelvic lymphocele; Percutaneous drainage; Prostate cancer; Case-report;
مقالات ISI آنتی ژن اختصاصی پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biomarkers; tumor; kallikreins; African Americans; neoplasm grading; AA; African American; DRE; digital rectal examination; GG; Grade Group; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Castration resistance; De novo metastatic disease; Metastatic prostate cancer; Prostate specific antigen; Treatment;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; neoplasm recurrence; local; prostatectomy; prognosis; ACM; all cause mortality; BCR; biochemical recurrence; CRPC; castration resistant prostate cancer; ePSADT; early PSADT; PCSM; prostate cancer specific mo
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm recurrence; local; prostate specific antigen; magnetic resonance imaging; biomarkers; tumor; 3D; 3-dimensional; 3TmpMRI; 3 Tesla prostate mpMRI; ADC; apparent diffusion coefficient; BCR; biochemical recurrence; mpMRI; multipa
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; high-intensity focused ultrasound ablation; registries; patient outcome assessment; biomedical technology; CRN; coordinated registry network; EPIC-26; Expanded Prostate Cancer Index Composite-26; FDA; Food and Drug Administration; HIF
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; stress; psychological; sexual dysfunction; physiological; urination disorders; quality of life; AJCC; American Joint Committee on Cancer; PCa; prostate cancer; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Spatial-resolved technology; Dual-signal-output ratiometry; Two different signal-tags; Accurate detection with high sensitivity; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; urinary incontinence; treatment outcome; quality of life; LUTS; lower urinary tract symptoms; ORRP; open radical retropubic prostatectomy; PSA; prostate specific antigen; RP; radical prostatectomy; RT; radiotherapy; UC;
Keywords: آنتی ژن اختصاصی پروستات; GO@AuNRs-GOD; Multiple signal amplification; Streptavidin-biotin; Electrochemiluminescence aptasensor; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; watchful waiting; prostatectomy; risk; safety; AS; active surveillance; JHU; Johns Hopkins University; MRI; magnetic resonance imaging; PSA; prostate specific antigen; PSAD; PSA density; RP; radical prostatectomy;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; watchful waiting; genomics; risk factors; pathology; surgical; GPS; Genomic Prostate Scoreâ¢; GrdGrp; Gleason grade group; LFP; likelihood of favorable pathology; LR; low risk; NCCN®; National Comprehensive Cancer Network®; PSA; pr
Keywords: آنتی ژن اختصاصی پروستات; Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
Keywords: آنتی ژن اختصاصی پروستات; AMS; American medical systems; bPFS; biochemical progression-free survival; CTCAE; common terminology criteria for adverse events; DMFS; distant metastasis-free survival; DSS; disease specific survival; GI; gastrointestinal; GU; genitourinary; Gy; gray;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; mass screening; socioeconomic factors; mortality; NH; nonHispanic; NHIS; National Health Interview Survey; PM; predicted marginal; PSA; prostate specific antigen; RR; rate ratio; SEER; Surveillance, Epidemio
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; magnetic resonance imaging; ultrasonography; biopsy; diagnostic imaging; CS-PCA; clinically significant PCA; MRI; magnetic resonance imaging; PCA; prostate cancer; PI-RADS⢠v2; Prostate Imaging Reporting and Data System, version 2;
Keywords: آنتی ژن اختصاصی پروستات; Biological variation; Analytical performance specification; Prostate specific antigen; Prostate cancer;
Keywords: آنتی ژن اختصاصی پروستات; ADC; apparent diffusion coefficient; DWI; diffusion, weighted imaging; GLCM; grey level co-occurrence matrix; MRI; magnetic resonance imaging; PSA; prostate specific antigen; ROI; region of interest; Prostate cancer bone metastases; Apparent diffusion coe
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; image-guided biopsy; magnetic resonance imaging; ultrasonography; diagnostic imaging; AS; anterior stroma; FUS-GB; MRI/ultrasound fusion guided biopsy; GS; Gleason score; mp-MRI; multiparametric MRI; MRI; magnetic resonance imaging; P
Keywords: آنتی ژن اختصاصی پروستات; BF; biochemical failure; BR; biochemical recurrence; BS; biochemical success; CI; confidence interval; EBRT; external-beam radiotherapy; IPSS; International Prostate Symptom Score; PAE; prostatic artery embolization; PCa; prostate cancer; PSA; prostate sp
Keywords: آنتی ژن اختصاصی پروستات; ANGPTL4; angiopoietin-like 4; CDX; CTC-derived xenograft; CK; cytokeratin; CNA; copy number alteration; CTC; circulating tumor cell; DAXX; death-associated protein 6; EMT; epithelial-mesenchymal transition; EpCAM; epithelial adhesion molecules; INDEL; ins
Keywords: آنتی ژن اختصاصی پروستات; Prostate cancer; Biomarker; Diagnosis; Prognosis; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Prostate cancer recurrence; Androgen deprivation therapy (ADT); Choline-PET/CT; PSMA-PET/CT; Robotic salvage lymph node dissection; Complete biochemical response (cBCR); ADT; androgen deprivation therapy; BCR; biochemical recurrence; cBCR; complete bioche
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm grading; prostatectomy; watchful waiting; clinical decision-making; AS; active surveillance; ASIST; Active Surveillance Magnetic Resonance Imaging Study; BCR; biochemical recurrence; EPE; extraprostatic extension; GrdGrp; Gra
Keywords: آنتی ژن اختصاصی پروستات; World Trade Center; WTC; Screening; Cancer; Breast; Prostate; Mammography; Prostate specific antigen; Disaster; Rescue and recovery;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; watchful waiting; neoplasm grading; prostatectomy; risk factors; AS; active surveillance; BCR; biochemical recurrence-free; FIR; favorable intermediate risk; GG; Grade Group; GS; Gleason score; LNI; lymph node involvement; LR; low ris
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biopsy; inflammation; prostate-specific antigen; risk factors; PCa; prostate cancer; PNB; prostate needle biopsy; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biomarkers; tumor; neoplastic cells; circulating; bone marrow; neoplasm metastasis; 4P; PSA, PAP, PSCA and PSMA cocktail; AR; androgen receptor; BM; bone marrow; CK; pan-cytokeratin; CTC; circulating tumor cell; DTC; disseminated tumo
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; United States Food and Drug Administration; patient preference; clinical decision making; equipment and supplies; AS; active surveillance; BOO; bladder outlet obstruction; FDA; Food and Drug Administration; HIFU; high intensity focuse
Keywords: آنتی ژن اختصاصی پروستات; Prostate specific antigen; Biosensor; Peptide nanotube; Polyaniline; Gold nanoparticle;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; global burden of disease; incidence; mortality; ASDR; age standardized death rate; ASIR; age standardized incidence rate; DALY; disability adjusted life-year; GBD; Global Burden of Disease; PCa; prostate can
Keywords: آنتی ژن اختصاصی پروستات; prostate-specific antigen; prostatic neoplasms; transplantation; graft survival; cPSA; complexed PSA; ESLD; end stage liver disease; ESRD; end stage renal disease; fPSA; free PSA; HD; hemodialysis; MMF; mycophenolate mofetil; PSA; prostate specific antige
Keywords: آنتی ژن اختصاصی پروستات; PCa; prostate cancer; PSA; prostate specific antigen; DRE; digital rectal examination; PSAD; prostate specific antigen density; BPH; benign prostatic hyperplasia; AUC; area under curve; KATH; Komfo Anokye Teaching Hospital; ROC; receiver operating charact
Keywords: آنتی ژن اختصاصی پروستات; Insulin; C-peptide; IGF-1; Body composition; 1-RM; 1 Repetition Maximum; ADT; Androgen Deprivation Therapy; AUC; Area Under the Curve; BMI; Body Mass Index; CRP; C-reactive Protein; CVD; Cardiovascular Disease; DBP; Diastolic Blood Pressure; FFM; Fat Free
Keywords: آنتی ژن اختصاصی پروستات; CDK; cyclin-dependent kinase; PTMs; post-translational modifications; AR; androgen receptor; PCa; prostate cancer; PSA; prostate specific antigen; ENZ; enzalutamide; CSS; charcoal stripped serum; FBS; fetal bovine serum; ER; estrogen receptor; PR; progest
Keywords: آنتی ژن اختصاصی پروستات; IGZO; Indium gallium ZnO; CMOS; Complementary metal-oxide semiconductor; PAC; Polymer-like amorphous carbon; AFP; Anti-α-feptoprotein; PSA; Prostate specific antigen; cTnT; Cardiac troponin T; CEA; Carcinoembryonic antigen; PNA; Peptide nucleic acid; APT
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; mass screening; mortality; failure to rescue; health care; early detection of cancer; DRE; digital rectal examination; ERSPC; European Randomized study of Screening for Prostate Cancer; PSA; prostate specific antigen; TRUS; transrecta
Keywords: آنتی ژن اختصاصی پروستات; Visual; Ratiometry electrochemiluminescence; Bipolar electrode; Prostate specific antigen; CdTe quantum dots; DNA-modified gold nanorods;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; prostatectomy; neoplasm recurrence; local; early detection of cancer; BCR; biochemical recurrence; CSS; cancer specific survival; MFS; metastasis-free survival; PSA; prostate specific antigen; RP; radical pr
Keywords: آنتی ژن اختصاصی پروستات; 18-facet polyhedron Cu7S4 nanocrystals; CuS sphere; CuS flower; H2O2; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Prostate specific antigen; Electrochemical aptasensor; Signal amplification; Catalytic hairpin assembly;
Keywords: آنتی ژن اختصاصی پروستات; AA; ascorbic acid; ABTS; 2,2â²-azino-bis(3-ethylbenzthiazoline-6-sulfonicacid) diammonium salt; AEF; analytical enhancement factor; AFP; alpha fetoprotein; Anti-CEA; anticarcinoembryonic antibody; Au NBPs; gold nanobipyramids; AuNCs; gold nanoclusters; A
Keywords: آنتی ژن اختصاصی پروستات; Early diagnosis; General practice; Prostate cancer; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; guidelines as topic; prostate-specific antigen; advisory committees; AUA; American Urological Association; ERSPC; European Randomized Study of Screening for Prostate Cancer; PCa; prostate cancer; PLCO; Prostate, Lung, Colorectal and O
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; brachytherapy; androgen antagonists; disease-free survival; ADT; androgen deprivation therapy; bDFS; biochemical disease-free survival; BF; biochemical failure; EBRT; external beam radiotherapy; LDR-BT; low
Keywords: آنتی ژن اختصاصی پروستات; Metal-organic gel; Fluorescence anisotropy; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Urolithins; Prostate cancer; Interactions; Ellagitannins gut metabolites; ADT; androgen deprivation therapy; AR; androgen receptor; bic; bicalutamide; CI; combination index; DHT; dihydrotestosterone; GnRH; gonadotropin-releasing hormone; PSA; prostate spe
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; watchful waiting; mass screening; disease progression; AS; active surveillance; EPE; extraprostatic extension; GS; Gleason score; MRI; magnetic resonance imaging; PC; prostate cancer; PSA; prostate specific antigen; RP;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm recurrence; local; ultrasound; high-intensity focused; transrectal; postoperative complications; salvage therapy; ADT; androgen deprivation therapy; AE; adverse event; CaP; prostate cancer; EBRT; external beam radiation thera
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; high-intensity focused ultrasound ablation; cryotherapy; robotic surgical procedures; ADT; androgen deprivation therapy; BCR; biochemical recurrence; EBRT; external beam radiotherapy; HIFU; high intensity focused ultras